BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21111719)

  • 1. Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells.
    Kim KY; Cho HS; Lee SH; Ahn JH; Cheon HG
    Brain Res; 2011 Feb; 1372():103-14. PubMed ID: 21111719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
    Kim KY; Ahn JH; Cheon HG
    Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential anti-proliferative actions of peroxisome proliferator-activated receptor-gamma agonists in MCF-7 breast cancer cells.
    Kim KY; Kim SS; Cheon HG
    Biochem Pharmacol; 2006 Aug; 72(5):530-40. PubMed ID: 16806087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
    Yuan Y; Zhang A; Huang S; Ding G; Chen R
    Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KR-62980: a novel peroxisome proliferator-activated receptor gamma agonist with weak adipogenic effects.
    Kim KR; Lee JH; Kim SJ; Rhee SD; Jung WH; Yang SD; Kim SS; Ahn JH; Cheon HG
    Biochem Pharmacol; 2006 Aug; 72(4):446-54. PubMed ID: 16797489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma stimulation promotes mitochondrial biogenesis and prevents glucose deprivation-induced neuronal cell loss.
    Miglio G; Rosa AC; Rattazzi L; Collino M; Lombardi G; Fantozzi R
    Neurochem Int; 2009 Dec; 55(7):496-504. PubMed ID: 19442697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoflurane preconditioning protects human neuroblastoma SH-SY5Y cells against in vitro simulated ischemia-reperfusion through the activation of extracellular signal-regulated kinases pathway.
    Zuo Z; Wang Y; Huang Y
    Eur J Pharmacol; 2006 Aug; 542(1-3):84-91. PubMed ID: 16806162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of the new thiadiazolidinone NP00111 against oxygen-glucose deprivation in rat hippocampal slices: implication of ERK1/2 and PPARgamma receptors.
    Rosa AO; Egea J; Martínez A; García AG; López MG
    Exp Neurol; 2008 Jul; 212(1):93-9. PubMed ID: 18471812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
    Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
    J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of peroxisome proliferator-activated receptor γ, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage.
    Lee CH; Park OK; Yoo KY; Byun K; Lee B; Choi JH; Hwang IK; Kim YM; Won MH
    J Neurol Sci; 2011 Jan; 300(1-2):120-9. PubMed ID: 20880548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production.
    Jung TW; Lee JY; Shim WS; Kang ES; Kim SK; Ahn CW; Lee HC; Cha BS
    J Neurol Sci; 2007 Feb; 253(1-2):53-60. PubMed ID: 17266988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide.
    Gonon AT; Bulhak A; Labruto F; Sjöquist PO; Pernow J
    Basic Res Cardiol; 2007 Jan; 102(1):80-9. PubMed ID: 16900441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone protects human neuroblastoma SH-SY5Y cells against acetaldehyde-induced cytotoxicity.
    Jung TW; Lee JY; Shim WS; Kang ES; Kim SK; Ahn CW; Lee HC; Cha BS
    Biochem Biophys Res Commun; 2006 Feb; 340(1):221-7. PubMed ID: 16360119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of caveolin-1, nitric oxide, and nitric oxide synthases in hypoxic human SK-N-MC neuroblastoma cells.
    Shen J; Lee W; Li Y; Lau CF; Ng KM; Fung ML; Liu KJ
    J Neurochem; 2008 Oct; 107(2):478-87. PubMed ID: 18717816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
    Luo Y; Yin W; Signore AP; Zhang F; Hong Z; Wang S; Graham SH; Chen J
    J Neurochem; 2006 Apr; 97(2):435-48. PubMed ID: 16539667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
    Tencer L; Burgermeister E; Ebert MP; Liscovitch M
    Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
    Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
    Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.
    Tao L; Liu HR; Gao E; Teng ZP; Lopez BL; Christopher TA; Ma XL; Batinic-Haberle I; Willette RN; Ohlstein EH; Yue TL
    Circulation; 2003 Dec; 108(22):2805-11. PubMed ID: 14610009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
    Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.